Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
Gilead cancels HIV trial as clinical hold remains intact
After discussions with the FDA, Gilead is discontinuing the Wonders-2 trial comparing the combo of GS-1720 and GS-4182 to Biktarvy.
Darren Incorvaia
Apr 1, 2026 4:50pm
PepGen hit with partial hold, analyst blames 'understaffed FDA'
Mar 5, 2026 5:45am
FDA fully releases clinical hold on Intellia CRISPR trials
Mar 2, 2026 10:55am
FDA freezes enrollment in MacroGenics cancer trial after death
Feb 24, 2026 2:00pm
FDA rejects Regenxbio's Hunter syndrome gene therapy
Feb 9, 2026 4:05pm
Brain tumor prompts FDA hold for 2 Regenxbio gene therapies
Jan 28, 2026 9:42am